| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order | 
|---|---|---|---|---|---|---|
| 135843-1G | 
                     | 
                1372719-93-1 | 
                     (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C45H31O4P | |
| 135843-100MG | 
                     | 
                1372719-93-1 | 
                     (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C45H31O4P | |
| 135843-25MG | 
                     | 
                1372719-93-1 | 
                     (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C45H31O4P | |
| 135846-1G | 
                     | 
                1393527-23-5 | 
                     (11aS)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C45H31O4P | |
| 135846-100MG | 
                     | 
                1393527-23-5 | 
                     (11aS)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C45H31O4P | |
| 135846-25MG | 
                     | 
                1393527-23-5 | 
                     (11aS)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C45H31O4P | |
| 135845-1G | 
                     | 
                1345628-08-1 | 
                     (11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C45H31O4P | |
| 135845-100MG | 
                     | 
                1345628-08-1 | 
                     (11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C45H31O4P | |
| 135845-25MG | 
                     | 
                1345628-08-1 | 
                     (11aR)-3,7-Di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C45H31O4P | |
| 134997-1G | 
                     | 
                1258327-06-8 | 
                     (11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C41H31O4P | |
| 134997-100MG | 
                     | 
                1258327-06-8 | 
                     (11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C41H31O4P | |
| 134997-25MG | 
                     | 
                1258327-06-8 | 
                     (11aS)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C41H31O4P | |
| 134998-1G | 
                     | 
                1297613-77-4 | 
                     (11aR)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C41H31O4P | |
| 134998-100MG | 
                     | 
                1297613-77-4 | 
                     (11aR)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C41H31O4P | |
| 134998-25MG | 
                     | 
                1297613-77-4 | 
                     (11aR)-3,7-Bis([1,1'-biphenyl]-4-yl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C41H31O4P | |
| 134901-1G | 
                     | 
                1258276-28-6 | 
                     (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C47H59O4P | |
| 134901-100MG | 
                     | 
                1258276-28-6 | 
                     (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C47H59O4P | |
| 134901-25MG | 
                     | 
                1258276-28-6 | 
                     (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                25MG | C47H59O4P | |
| 134900-1G | 
                     | 
                1372719-95-3 | 
                     (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                1G | C47H59O4P | |
| 134900-100MG | 
                     | 
                1372719-95-3 | 
                     (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin ≥98%,99%e.e.  | 
                100MG | C47H59O4P | |